Sign in
4

Changes in Ownership

Seres Therapeutics, Inc. Filed Acc 0000899243-20-011277

Options or other derivatives

  • Chapman Marcus acquired 18,596 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Chapman Marcus

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-04-22 Grant or award : show line 1 in the form STOCK OPTION (RIGHT TO BUY) +18,596 $3.74 2030-04-21 18,596 18,596 D
Loading xslF345X03/doc4.xml…